A novel c-Met inhibitor, MK8033, synergizes with carboplatin plus paclitaxel to inhibit ovarian cancer cell growth
about
Ockham's razor for the MET-driven invasive growth linking idiopathic pulmonary fibrosis and cancerMolecular Subtyping of Serous Ovarian Cancer Based on Multi-omics Data.Dasatinib + Gefitinib, a non platinum-based combination with enhanced growth inhibitory, anti-migratory and anti-invasive potency against human ovarian cancer cells.c-Met signaling in the development of tumorigenesis and chemoresistance: potential applications in pancreatic cancerSorafenib and DE605, a novel c-Met inhibitor, synergistically suppress hepatocellular carcinoma.Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft modelsMicroRNA-224 promotes the sensitivity of osteosarcoma cells to cisplatin by targeting Rac1.c-MET as a Potential Therapeutic Target in Ovarian Clear Cell Carcinoma.INC280, an orally available small molecule inhibitor of c-MET, reduces migration and adhesion in ovarian cancer cell modelscMET in NSCLC: Can We Cut off the Head of the Hydra? From the Pathway to the Resistance.Monitoring of ovarian cancer cell invasion in real time with frequency-dependent impedance measurement.HGF/c-MET Axis in Tumor Microenvironment and Metastasis Formation.Prognostic impact of high c-Met expression in ovarian cancer: a meta-analysis
P2860
Q28067777-2081B76C-CCBF-48D5-829C-4B85C9893108Q31096420-75A153F0-0C60-4A0E-81F9-0FD1DB00E460Q33604480-E9276D0A-64C5-4228-B009-29F26B295178Q33886974-DDD3F0FD-215C-4A44-9528-6FA6940EA4CEQ35828564-568EBB64-103B-414F-90AC-D0DD92077806Q35953034-3088C966-DF75-4DD4-B2C0-847131BD0D5AQ36944910-837548B1-63E8-42C0-824E-3BAF84FE987EQ37472110-80AB6909-E188-4F1E-AB03-78943F2E44F5Q37502372-7B960F99-DAD9-4B91-A7E3-F42F836DA975Q38393333-49C293EA-9E46-4373-9AED-AE9E18503F7AQ38736435-FF71BED0-2F1F-46FD-B478-C91871CA5D9DQ51152435-9831E9BD-D68D-40BC-882A-F809F5B54B8AQ57493808-8AE7E94D-FDD6-4533-B56A-23F59E9F1EDC
P2860
A novel c-Met inhibitor, MK8033, synergizes with carboplatin plus paclitaxel to inhibit ovarian cancer cell growth
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
A novel c-Met inhibitor, MK803 ...... bit ovarian cancer cell growth
@ast
A novel c-Met inhibitor, MK803 ...... bit ovarian cancer cell growth
@en
type
label
A novel c-Met inhibitor, MK803 ...... bit ovarian cancer cell growth
@ast
A novel c-Met inhibitor, MK803 ...... bit ovarian cancer cell growth
@en
prefLabel
A novel c-Met inhibitor, MK803 ...... bit ovarian cancer cell growth
@ast
A novel c-Met inhibitor, MK803 ...... bit ovarian cancer cell growth
@en
P2093
P2860
P356
P1433
P1476
A novel c-Met inhibitor, MK803 ...... bit ovarian cancer cell growth
@en
P2093
Alex S Lopez
Anders Berglund
Christopher L Cubitt
Douglas C Marchion
Elona Bicaku
Entidhar Al Sawah
Johnathan M Lancaster
Nadim Bou Zgheib
Patricia L Judson
Robert M Wenham
P2860
P304
P356
10.3892/OR.2013.2329
P577
2013-03-05T00:00:00Z